Microbot Medical, MBOT, is a pre-clinical medical device company. The Company specializes in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms include LIBERTY, NovaCross, One & Done, ViRob and TipCAT. LIBERTY is designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body’s vasculature. 

 Note: After we published this article MBOT gained an additional 73%. Stock closed at $3.19 up 159% for the day!

The Company Announced Today: 

Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians 

A team of six leading European interventional radiologists used the LIBERTY® Surgical Robotic System and performed a total of 48 catheterizations 

HINGHAM, Mass., May 22, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Surgical Robotic System, the first single-use endovascular robotic system, today announced a highly successful extended joint pre- clinical animal study held at a leading European-based research lab. 
 

A team of six leading European interventional radiologists utilized the system and performed a total of 48 catheterizations to pre-determined vascular targets including distal branches of hepatic, gastric, splenic, mesenteric, renal, and hypogastric arteries, with a 100% success rate of reaching the intended target. learn more 

Othere Stocks to Watch Today! 

AVIR, ABSI, BIOR